QBH-196

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameQBH-196
Drug Alias NameQBH-196
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHepatocyte growth factor receptor inhibitors
TargetsHepatocyte growth factor receptorStem cell growth factor receptorVascular endothelial growth factor receptor 2 +[6] 
Therapy Area/IndicationsSolid tumoursStomach Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShenyang Pharmaceutical University
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesChina Resources Sanjiu Medical & Pharmaceutical Co LtdShenyang Pharmaceutical University
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsStomach Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A